To the best of our knowledge, this is the first investigation to validate the association of neuroblastoma susceptibility with GWAS-identified polymorphism within LINC00673. The identification of LINC00673 as an antitumor factor in neuroblastoma was based on discoveries in GWASs in several tumors. This evidence concerns the gene LINC00511 and neuroblastoma.